Get the Stockscreener App
0.8508
1.29%
0.0108
After Hours:
.82
-0.0308
-3.62%
22nd Century Group, Inc. stock is traded at $0.8508, with a volume of 652.80K.
It is up +1.29% in the last 24 hours and down -60.43% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$0.84
Open:
$0.82
24h Volume:
652.80K
Relative Volume:
0.61
Market Cap:
$941.30K
Revenue:
$17.59M
Net Income/Loss:
$-13.12M
P/E Ratio:
-0.00395
EPS:
-215.5494
Net Cash Flow:
$-8.60M
1W Performance:
-47.16%
1M Performance:
-60.43%
6M Performance:
-95.43%
1Y Performance:
-95.23%
1-Day Range:
$0.82
$0.863
1-Week Range:
$0.7898
$1.9699
52-Week Range:
$0.7898
$168.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
0.8508 | 929.36K | 17.59M | -13.12M | -8.60M | -215.55 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Announced May 7 Financial Call - Tobacco Reporter
MSN Money - MSN
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings - Benzinga
22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 - The Manila Times
22nd Century to post Q1 results at 6 a.m., webcast at 8 - Stock Titan
XXII Stock Chart | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Group, Inc. Files 8-K with SEC Detailing Material Definitive Agreement and NASDAQ Listing - Minichart
22nd Century Files Prospectus for Potential ATM Stock Offering - TipRanks
22nd Century Group Announces $6.4 Million ATM Offering With Needham as Sales Agent - TradingView
22nd Century (NASDAQ: XXII) clears $6,400,000 common stock sale path - Stock Titan
XXII Holdings (NASDAQ: XXII) registers $6.4M ATM program with Needham - Stock Titan
XXII Stock Slides As Volatility Attracts Active Traders - StocksToTrade
22nd Century Group (XXII) slides 12.6% as rally fades and dilution risk stays in focus - Quiver Quantitative
XXII Stock Slides As Volatility Spikes And Cash Burn Persists - timothysykes.com
XXII Stock Draws Traders As VLN Growth Story Accelerates - StocksToTrade
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Benzinga
XXII Price Today: 22nd Century Group Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership - The Manila Times
FDA-authorized low-nicotine cigarette maker plans wider 2026 rollout - Stock Titan
[DEF 14A] 22nd Century Group, Inc. Definitive Proxy Statement - Stock Titan
XXII - Finviz
22nd Century Group's reduced nicotine bet falls flat with investors - MSN
22nd Century Appoints Robert Manfredonia as Executive Vice President of Sales and Marketing - TMX Newsfile
22nd Century Group (XXII) Signs Large New CMO Customer - TMX Newsfile
22nd Century Group Completes Sale of Hemp/Cannabis Franchise - TMX Newsfile
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule - TMX Newsfile
22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction - TMX Newsfile
22nd Century Group Announces Partial Adjournment of Annual Meeting for Proposal 2, All Other Proposals Passed - TMX Newsfile
22nd Century Eliminates an Additional $2.3 Million of Debt - TMX Newsfile
22nd Century Announces Resignation of John Miller as President of Tobacco - TMX Newsfile
22nd Century Group Provides Update on Incident at Grass Valley Facility - TMX Newsfile
22nd Century Group Provides Update on Grass Valley Facility - TMX Newsfile
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms - TMX Newsfile
22nd Century Announces New Greenbutts Manufacturing Agreement for Innovative Plant-Based, Biodegradable Cigarette Filters - TMX Newsfile
22nd Century Announces New Branded Products Order with Customer for Southeast Asia - TMX Newsfile
22nd Century Group Reports Second Quarter 2024 Financial Results - TMX Newsfile
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - TMX Newsfile
22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume - TMX Newsfile
22nd Century Group to effect 1-for-15 reverse stock split for Nasdaq compliance - MSN
22nd Century (XXII) Partners with NC State for Tobacco Testing S - GuruFocus
Is 22nd (XXII) stock outperforming the market | 22nd Century Group Inc delivers 98.8% EPS beat vs consensus estimatesMargin Expansion - Cổng thông tin điện tử tỉnh Lào Cai
22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University - The Manila Times
XXII Q1'26 Earnings: revenue estimate is 4.61M USD - TradingView
Low-nicotine tobacco project pairs 22nd Century with NC State on yields - Stock Titan
XXII Technical Analysis | Trend, Signals & Chart Patterns | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Group misses Q4 top-line estimates - MSN
XXII SEC Filings22Nd Century 10-K, 10-Q, 8-K Forms - Stock Titan
Form 8-KCurrent report - ADVFN
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
Form S-3Registration statement under Securities Act of 1933 - ADVFN
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):